BDBM667079 US20240116947, Example 23::methyl 2-{[2-({4-[7-(5-chloro-2- fluorophenyl)- 1H,2H,3H-pyrido[3,4- b][1,4]oxazin-1-yl]pyridin-2- yl}carbamoyl)ethyl](methyl)amino} acetate

SMILES COC(=O)CN(C)CCC(=O)Nc1cc(ccn1)N1CCOc2cnc(cc12)-c1cc(Cl)ccc1F

InChI Key InChIKey=BJMQQIPKUFIBCZ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 667079   

TargetTGF-beta receptor type-1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM667079(US20240116947, Example 23 | methyl 2-{[2-({4-[7-(5...)
Affinity DataIC50: 1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent